PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 91 filers reported holding PASSAGE BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $218,657 | -30.0% | 332,203 | +0.1% | 0.00% | – |
| Q2 2023 | $312,430 | -1.7% | 331,914 | 0.0% | 0.00% | – |
| Q1 2023 | $317,874 | +69304.8% | 331,914 | 0.0% | 0.00% | – |
| Q4 2022 | $458 | -99.9% | 331,914 | -5.8% | 0.00% | – |
| Q3 2022 | $440,000 | -47.0% | 352,537 | +0.2% | 0.00% | – |
| Q2 2022 | $830,000 | -58.5% | 351,727 | -45.5% | 0.00% | – |
| Q1 2022 | $2,000,000 | -53.2% | 645,311 | -4.0% | 0.00% | -100.0% |
| Q4 2021 | $4,269,000 | -9.4% | 672,325 | +42.0% | 0.00% | 0.0% |
| Q3 2021 | $4,714,000 | -32.7% | 473,328 | -10.5% | 0.00% | 0.0% |
| Q2 2021 | $7,005,000 | -9.8% | 529,095 | +19.0% | 0.00% | 0.0% |
| Q1 2021 | $7,769,000 | -5.4% | 444,490 | +38.4% | 0.00% | 0.0% |
| Q4 2020 | $8,211,000 | +193.0% | 321,119 | +50.2% | 0.00% | 0.0% |
| Q3 2020 | $2,802,000 | -51.5% | 213,747 | +1.1% | 0.00% | 0.0% |
| Q2 2020 | $5,779,000 | – | 211,461 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1,648,629 | 2.12% |
| Versant Venture Management, LLC | 4,959,769 | $3,263,528 | 1.74% |
| BML Capital Management, LLC | 2,058,767 | $1,354,669 | 1.24% |
| Acuitas Investments, LLC | 418,161 | $275,150 | 0.16% |
| Orbimed Advisors | 10,124,576 | $6,661,971 | 0.14% |
| Lynx1 Capital Management LP | 190,124 | $125,102 | 0.08% |
| Frazier Life Sciences Management, L.P. | 1,758,219 | $1,156,908 | 0.08% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $263,200 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $56,621 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 506,600 | $333,343 | 0.01% |